Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 257 followers
Latest posts
Last updated about 6 hours ago
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 8, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date...
Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation: 28/03/2019, Revision: 13, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Ajovy, fremanezumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Opsumit, macitentan, Date of authorisation: 20/12/2013, Revision: 25, Status: Authorised
about 6 hours ago
Human medicines European public assessment report (EPAR): Opsumit, macitentan, Date of authorisation...
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 21, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of...
Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Date of...
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine...
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 7, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation...
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Date of authorisation...
Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord, vildagliptin / metformin hydrochloride, Date of authorisation: 24/03/2022, Revision: 3, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Vildagliptin / Metformin hydrochloride Accord...